Role of transglutaminase 2 in glucose tolerance: Knockout mice studies and a putative mutation in a MODY patient

FASEB Journal

Volumn 16, Issue 11, 2002, Pages 1371-1378

  Bernassola, Francesca ^a   Federiciz, Massimo ^b   Corazzari, Marco ^a   Terrinoni, Alessandro ^a   Hribal, Marta L ^b   De Laurenzi, Vincenzo ^a   Ranalli, Marco ^a   Massa, Ornella ^c   Sesti, Giorgio ^d   Irwin Mclean, W H ^e   Citro, Gennaro ^f   Barbetti, Fabrizio ^c,g   Melino, Gerry ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IBCIT Biomedical Science Park Rome S Raffaele   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Diabetes; Insulin; Mature onset diabetes of the young

Indexed keywords

GLUCOSE; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSGLUTAMINASE 2; UNCLASSIFIED DRUG;

AMIDATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CATALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ENZYME ACTIVE SITE; ENZYME REGULATION; GENE DISRUPTION; GENE IDENTIFICATION; GENE MUTATION; GLUCOSE TOLERANCE; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; ITALY; KNOCKOUT MOUSE; MATURITY ONSET DIABETES MELLITUS; MISSENSE MUTATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REACTION ANALYSIS;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; CHILD; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; GTP-BINDING PROTEINS; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; KINETICS; MALE; MICE; MICE, KNOCKOUT; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTOR, INSULIN; SEQUENCE HOMOLOGY, AMINO ACID; TRANSGLUTAMINASES;

ANIMALIA;

EID: 0036720319     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0689com     Document Type: Article

References (39)

1. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity
2. S-nitrosylation regulates apoptosis
3. Gh: A GTP-binding protein with transglutaminase activity and receptor signaling function
4. The promoter of mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expression
5. Tissue transglutaminase in apoptosis: A downstream or a multifunctional upstream effector?
6. Tissue-Transglutaminase and apoptosis: Sense and antisense transfection studies in human neuroblastoma cells
7. Gene disruption of tissue transglutaminase
8. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm
9. Transglutaminase activity in pancreatic islets
10. Role of transglutaminase in insulin release. Study with glycine and sarcosine methyl esters
11. A role for transglutaminase in glucose-stimulated insulin release from the pancreatic beta-cell
12. Vitamin A stimulation of insulin secretion: Effects on transglutaminase mRNA and activity using rat islets and insulin-secreting cells
13. Regulation of insulin receptors: Evidence for involvement of an endocytotic internalization pathway
14. Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones
15. Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells
16. Disruption of IRS-2 causes type 2 diabetes in mice
17. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue
18. Development of a novel polygenic model of NIDDM in mice heterozygous for 1R and IRS-1 null alleles
19. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice
20. Assays for transglutaminases in cell death
21. The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets
22. The Gly972- > Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells
23. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI
24. MODY 2 presenting as neonatal hyperglycemia: A need to re-shape the definition of 'neonatal diabetes'?
25. Neonatal diabetes mellitus due to complete glucokinase deficiency
26. The second activating glucokinase mutation (A456V): Implications for glucose homeostasis and diabetes therapy
27. Maturity onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
28. Molecular mechanisms and clinical pathophysiology of maturity onset diabetes of the young
29. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in Caucasians
30. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity
31. Genetics of non-insulin-dependent (type-II) diabetes mellitus
32. Putting the genes for type II diabetes on the map
33. Lymphocyte transglutaminase function may be impaired in type 2 diabetes mellitus
34. The intermediate filament protein, vimentin, in the lens is a target for cross-linking by transglutaminase
35. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis
36. Association of a transglutaminase-related antigen with intermediate filaments
37. Role of transglutaminase in proinsulin conversion and insulin release
38. Glucose- and GTP-dependent stimulation of the carboxyl methylation of CDC42 in rodent and human pancreatic islets and pure beta cells. Evidence for an essential role of GTP binding proteins in nutrient-induced insulin secretion
39. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2